ATXA Therapeutics is a clinical-stage pharmaceutical company committed to the advancement of innovative, life-changing treatments for cardiopulmonary diseases. Our research focuses on developing novel antagonists of the Thromboxane Receptor (TP), a key driver of disease within the heart & lungs. ATXA’s world class team encompasses leading experts in the relevant fields, including scientists, clinicians, and commercial strategists with extensive experience and noted successes in the field of drug development and commercialization. Driven by innovative research, our aim is to bring accessible, affordable and life-changing treatments to patients with cardiopulmonary diseases, offering them new hope and bettering their lives.
View Top Employees from ATXA TherapeuticsWebsite | https://www.atxatherapeutics.com/ |
Revenue | $4 million |
Employees | 6 (5 on RocketReach) |
Founded | 2015 |
Address | 75 Avoca Park Avoca Ave, Blackrock A94 N803, IE |
Phone | +353 87 776 5446 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Pharmaceutical, Retail, Health Care, Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular ATXA Therapeutics employee's phone or email?
The ATXA Therapeutics annual revenue was $4 million in 2024.
5 people are employed at ATXA Therapeutics.
The NAICS codes for ATXA Therapeutics are [32, 32541, 3254, 325].
The SIC codes for ATXA Therapeutics are [283, 28].